Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission
Tóm tắt
Administration of 10 mg/kg TRH to mice was found to reduce the sleep and hypothermia induced by 4.7 g/kg ethanol. However, TRH did not reduce the sleep of mice that were given γ-hydroxybutyric acid (GHBA), baclophen, or aminooxyacetic acid (AOAA) in combination with 3 g/kg ethanol. TRH also failed to reverse the hypothermia induced by the combination of ethanol and baclophen or GHBA, and the characteristic neurological effects of TRH e.g. tremor, increased muscle tone, and increased respiratory rate were reduced. In addition, TRH-induced locomotor stimulation was prevented by pretreatment with small doses of the GABA-ergic agents, and while 30 mg/kg TRH reduced the hypothermia produced by large doses of the GABA-ergic drugs, it did not antagonize the locomotor retardation produced by baclophen or GHBA. A hypothesis that the analeptic effects of TRH may be mediated via an inhibition of GABA systems is discussed.
Tài liệu tham khảo
Aghajanian, G. K., Roth, R. H.: γ-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131–138 (1970)
Andén, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89–92 (1973)
Andén, N. E., Wachtel, H.: Biochemical effects of baclofen (β-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta pharmacol. (Kbh.) 40, 310–320 (1977)
Beleslin, D. B., Samardzic, R.: Failure of autonomic and central nervous system blocking agents to antagonize the groos behavioural effects of tubocurarine injected intraventricularly in conscious cats. J. Pharm. Pharmacol. 28, 519 (1976)
Breese, G. R., Cooper, B. R., Prange, A. J., Cott, J. M., Lipton, M. A.: Interactions of thyrotropin-releasing hormone with centrally acting drugs. In: The thyroid axis, drugs and behavior, A. J. Prange, ed., pp. 115–127. New York: Raven Press 1974a
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A.: Antagonism of ethanol narcosis by thyrotropin-releasing hormone. Life Sci. 14, 1053–1063 (1974b)
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A., Plotnikoff, N. P.: Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J. Pharmacol. exp. Ther. 193, 11–22 (1975)
Brown, M., Vale, W.: Central nervous system effects of hypothalamic peptides. Endocrinology 96, 1333–1336 (1975)
Carlsson, A.: Pharmacological approach to schizophrenia. In: Schizophrenia: Biological and physiological perspectives, G. Usdin, ed., pp. 102–124. New York: Brunner/Mazel Pub. 1975
Cohn, M. L.: Cyclic AMP, thyrotropin-releasing factor, and somatostatin: Key factors in the regulation of the duration of narcosis. In: Molecular mechanisms of anesthesia, progress in anesthesiology, Vol. 1, B. R. Fink, ed., pp. 485–500. New York: Raven Press 1975
Collins, G. G. S.: GABA-2-oxoglutarate transaminase, glutamate decarboxylase and the half-life of GABA in different areas of rat brain. Biochem. Pharmacol. 21, 2849–2858 (1972)
Cott, J. M., Breese, G. R., Cooper, B. R., Barlow, T. S., Prange, A. J., Jr.: Investigation into the mechanism of reduction of ethanol sleep by thyrotroping-releasing hormone (TRH). J. Pharmacol. exp. Ther. 196, 594–604 (1976a)
Cott, J. M., Carlsson, A., Engel, J., Lindqvist, M.: Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 203–209 (1976b)
Curtis, D. R., Game, C. J. A., Johnston, G. A. R., McCulloch, R. M.: Central effects of β-(-p-chlorophenyl)-γ-aminobutyric acid. Brain Res. 70, 493–499 (1974)
Davies, J., Watkins, J. C.: The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex. Brain Res. 70, 501–505 (1974)
Dray, A., Straughan, D. W.: Synaptic mechanisms in the substantia nigra. J. Pharm. Pharmacol. 28, 400–405 (1976)
Fahn, S.: Regional distribution studies of GABA and other putative neurotransmitters and their enzymes. In: GABA in nervous system function, E. Roberts, T. N. Chase, and D. B. Tower, eds., pp. 169–186. New York: Raven Press 1976
Fuxe, K., Agnati, L. F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, Å.: The effect of dopamine receptor stimulating and blocking agents on the activity of supersensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975a)
Fuxe, K., Hökfelt, T., Ljungdahl, Å., Agnati, L., Johansson, O., Perez de la Mora, M.: Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177–183 (1975b)
Haefely, W.: Paper presented at the 10th C.I.N.P. meeting, Quebec 1976
Hill, R. G., Simmonds, M. A., Straughan, D. E.: A comparative study of some convulsant substances as γ-aminobutyric acid antagonists in the feline cerebral cortex. Brit. J. Pharmacol. 49, 37–51 (1973)
Hökfelt, T., Fuxe, K., Johansson, O., Jeffcoat, S., White, N.: Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Europ. J. Pharmacol. 34, 389–392 (1975)
Horita, A., Carino, M. A.: Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits. Psychopharm. Commun. 1, 403–414 (1975)
Hornykiewicz, O., Lloyd, K. G., Davidson, L.: The GABA system, function of the basal ganglia, and Parkinson's disease. In: GABA in nervous system function, E. Roberts, T. N. Chase, and O. B. Tower, eds., pp. 479–485. New York: Raven Press 1976
Horst, W. D., Spirt, N.: A possible mechanism of the antidepressant activity of thyrotropin releasing hormone. Life Sci. 15, 1073–1082 (1974)
Kääriäinen, I.: Effects of aminooxyacetic acid and baclofen on the catalepsy and the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Acta pharmacol. (Kbh.) 39, 393–400 (1976)
McKenzie, G. M., Viik, K.: Chemically induced choreiform activity: antagonism by GABA and EEG patterns. Exp. Neurol. 46, 229–243 (1975)
Melberg, P.-E., Ahlenius, S., Engel, J., Lundborg, P.: Ontogenic development of locomotor activity and rate of tyrosine hydroxylation. Psychopharmacology 49, 119–123 (1976)
Plotnikoff, N. P., Prange, A. J., Jr., Breese, G. R., Anderson, M. S., Wilson, I. C.: Thyrotropin-releasing hormone: enhancement of DOPA activity by a hypothalamic hormone. Science 178, 417–418 (1972)
Prange, A. J., Breese, G. R., Cott, J. M., Martin, B. R., Cooper, B. R., Wilson, I. C., Plotnikoff, N. P.: Thyrotropin-releasing hormone: antagonism of pentobarbital in rodents. Life Sci. 14, 447–455 (1974)
Roberts, E.: A model of the vertebrate nervous system based largely on disinhibition: a key role of the GABA system. In: Neurohumoral coding of brain function, R. D. Myers, ed., pp. 419–449. New York: Plenum Press 1974
Roth, R. H., Suhr, Y.: Mechanism of the γ-hydroxybutyrate-induced increase in brain dopamine and its relationship to “sleep”. Biochem. Pharmacol. 19, 3001–3012 (1970)
Roth, R. H., Walters, J. R., Aghajanian, G. K.: Effects of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Frontiers of catecholamine research, E. Usdin and S. Snyder, eds., pp. 567–574. New York: Pergamon 1973
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973)
Wallach, D. P.: Studies on the GABA pathway. I. The inhibition of γ-aminobutyric acid α-ketogluturic acid transaminase in vitro and in vivo by U-7524 (aminooxyacetic acid). Biochem. Pharmacol. 5, 323–331 (1961)
Wood, J. D., Peesker, S. J.: The role of GABA metabolism in the convulsant and anticonvulsant actions of aminooxyacetic acid. J. Neurochem. 20, 379–386 (1973)